1975
DOI: 10.1042/bj1450159
|View full text |Cite
|
Sign up to set email alerts
|

Mechanistic, inhibitory and stereochemical studies on cytoplasmic and mitochondrial serine transhydorxymethylases

Abstract: By using cytoplasmic and mitochondrial serine transhydroxymethylase isoenzymes from rabbit liver, it was shown that both enzymes exhibited similar ratios of serine transhydroxymethylase/threonine aldolase activities. Both enzymes catalysed the removal of the pro-S hydrogen atom of glycine, which was greatly enhanced by the presence of tetrahydrofolate. The cytoplasmic as well as the mitochondrial enzyme catalysed the synthesis of serine from glycine and [3H2]formaldehyde in the absence of tetrahydrofolate. The… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
15
0

Year Published

1976
1976
2010
2010

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 16 publications
1
15
0
Order By: Relevance
“…In order to form L-serine from glycine the pro-2S proton of glycine must be replaced by a hydroxymethylene group. It is therefore not surprising that serine hydroxymethyltransferase has been shown to catalyse the exchange of the pro-2S proton of glycine (Jordan & Akhtar, 1970;Akhtar et al, 1975). These studies and a more recent study by Shostak & Schirch (1988) did not produce any evidence that serine hydroxymethyltransferase could catalyse the exchange of the pro-2R proton of glycine.…”
Section: Introductionmentioning
confidence: 99%
“…In order to form L-serine from glycine the pro-2S proton of glycine must be replaced by a hydroxymethylene group. It is therefore not surprising that serine hydroxymethyltransferase has been shown to catalyse the exchange of the pro-2S proton of glycine (Jordan & Akhtar, 1970;Akhtar et al, 1975). These studies and a more recent study by Shostak & Schirch (1988) did not produce any evidence that serine hydroxymethyltransferase could catalyse the exchange of the pro-2R proton of glycine.…”
Section: Introductionmentioning
confidence: 99%
“…Mechanistic and stereochemical studies showed that the cytoplasmic enzyme catalyses the aldol cleavage of allothreonine and the decarboxylation of aminomalonate as well as serine transhydroxymethylation, but the mitochondrial enzyme catalyses only the serine transhydroxymethylation [5]. However, both isoenzymes purified from rabbit liver, the cytoplasmic and the mitochondrial ones, exhibited similar ratios of serine transhydroxymethylase/threonine (allothreonine) aldolase activities [3]. The rabbit liver isoenzymes showed remarkable differences in their inactivation by inhibitors such as chloroacetaldehyde or glycinaldehyde [3].…”
Section: Discussionmentioning
confidence: 96%
“…However, both isoenzymes purified from rabbit liver, the cytoplasmic and the mitochondrial ones, exhibited similar ratios of serine transhydroxymethylase/threonine (allothreonine) aldolase activities [3]. The rabbit liver isoenzymes showed remarkable differences in their inactivation by inhibitors such as chloroacetaldehyde or glycinaldehyde [3]. These last properties have not been checked yet for the two yeast enzymic forms.…”
Section: Discussionmentioning
confidence: 99%
“…The basic features of this apparatus are probably still present in the current enzymes and represent the foundation of their similar catalytic properties. An aldolase is thought to break the C a -C b bond of 3-hydroxyamino acids, most probably through a retroaldol cleavage mechanism (Scheme 1), leaving a quinonoid intermediate (IIa) that, in SHMT, is then protonated from the same side of the cleaved bond (Scheme 1, reaction 2a), maintaining the configuration of the a-carbon [51,52]. The catalytic base responsible for the abstraction of a proton from the hydroxyl group of substrates and the protonation of the quinonoid (or the pro-2S proton abstraction from glycine in the reverse direction) must be located on the re face of the cofactor, opposite to the PLP-binding lysine (Lys229 in eSHMT, Lys197 in eTA and Lys235 in cAlaRac).…”
Section: Discussionmentioning
confidence: 99%